156
Views
4
CrossRef citations to date
0
Altmetric
Original Article

The effect of intravenously administered mexiletine on tinnitus-a pilot study

Los efectos de la administración intravenosa del mexiletine sobre el acúfeno – un estudio piloto

, , , , , & show all
Pages 689-696 | Published online: 07 Jul 2009

References

  • Berninger, E. 2000. Quinine as a model for the study of cochlear hearing loss in humans. Karolinska Institutet, Stockholm.
  • Berninger E., Karlsson K.K., Alvan G. Quinine reduces the dynamic range of the human auditory system. Acta Oto-Laryngologica 1998; 118: 46–51
  • Brunton, L.L., Lazo, J.S. & Parker, K.L., (eds.). 2006. Goodman and Gilman's the pharmacological basis of therapeutics, New York: McGraw-Hill.
  • Davis H. An active process in cochlear mechanics. Hearing Research 1983; 9: 79–90
  • den Hartigh J., Hilders C.G., Schoemaker R.C., Hulshof J.H., Cohen A.F., et al. Tinnitus suppression by intravenous lidocaine in relation to its plasma concentration. Clin Pharmacol Ther 1993; 54: 415–20
  • Dobie R.A. A review of randomized clinical trials in tinnitus. Laryngoscope 1999; 109: 1202–11
  • Duckert L.G., Rees T.S. Treatment of tinnitus with intravenous lidocaine: a double-blind randomized trial. Otolaryngol Head Neck Surg 1983; 91: 550–5
  • Haginomori S., Makimoto K., Araki M., Kawakami M., Takahashi H. Effect of lidocaine injection of EOAE in patients with tinnitus. Acta Otolaryngol 1995; 115: 488–92
  • Israel J.M., Connelly J.S., McTigue S.T., Brummett R.E., Brown J. Lidocaine in the treatment of tinnitus aurium. A double-blind study. Arch Otolaryngol 1982; 108: 471–473
  • Karlsson K.K., Berninger E., Gustafsson L.L., Alvan G. Pronounced quinine-induced cochlear hearing loss. A mechanistic study in one volunteer at multiple stable plasma concentrations. Journal of Audiological Medicine 1995; 4: 12–24
  • Kemp D.T. Otoacoustic emissions, travelling waves and cochlear mechanisms. Hearing Research 1986; 22: 95–104
  • Larsson B., Lyttkens L., Wasterstrom S.A. Tocainide and tinnitus. Clinical effect and site of action. ORL J Otorhinolaryngol Relat Spec 1984; 46: 24–33
  • Laurikainen E., Nuttall A.L., Miller J.M., Quirk W.S., Virolainen E. Experimental basis for lidocaine therapy in cochlear disorders. Acta Otolaryngol 1992; 112: 800–9
  • Laurikainen E.A., Johansson R.K., Kileny P.R. Effects of intratympanically delivered lidocaine on the auditory system in humans. Ear Hear 1996; 17: 49–54
  • Lenarz T. Treatment of tinnitus with lidocaine and tocainide. Scand Audiol Suppl 1986; 26: 49–51
  • Lenarz T., Gulzow J. Tinnitus therapy with lidocaine and tocainide]. Laryngol Rhinol Otol (Stuttg) 1985; 64: 604–8
  • Lockwood A.H., Salvi R.J., Burkard R.F. Tinnitus. N Engl J Med 2002; 347: 904–10
  • Lyttkens L. Pharmacological treatment of tinnitus with special reference to the role of melanin. Scand Audiol Suppl 1986; 26: 27–31
  • Lyttkens L., Larsson B., Wasterstrom S.A. Local anaesthetics and tinnitus. Proposed peripheral mechanism of action of lidocaine. ORL J Otorhinolaryngol Relat Spec 1984; 46: 17–23
  • Majumdar B., Mason S.M., Gibbin K.P. An electrocochleographic study of the effects of lignocaine on patients with tinnitus. Clin Otolaryngol 1983; 8: 175–80
  • Martin F.W., Colman B.H. Tinnitus: A double-blind crossover controlled trial to evaluate the use of lignocaine. Clin Otolaryngol 1980; 5: 3–11
  • McCormick M.S., Thomas J.N. Mexiletine in the relief of tinnitus: a report on a sequential double-blind crossover trial. Clin Otolaryngol 1981; 6: 255–8
  • Nobili R., Mammano F., Ashmore J. How well do we understand the cochlea?. Trends in Neurosciences 1998; 21: 159–67
  • Paczkowski D., Filipek M., Mielniczuk Z., Andrzejczak J., Poplawska W., et al. Simultaneous determination of mexiletine and four hydroxylated metabolites in human serum by high-performance liquid chromatography and its application to pharmacokinetic studies. J Chromatogr 1992; 573: 235–46
  • Paintaud G., Alvan G., Berninger E., Gustafsson L.L., Idrizbegovic E., et al. The concentration-effect relationship of quinine-induced hearing impairment. Clinical Pharmacology & Therapeutics 1994; 55: 317–23
  • Shibata N., Akabane M., Minouchi T., Ono T., Shimakawa H. Fluorimetric determination of mexiletine in serum by high-performance liquid chromatography using pre-column derivatization with fluorescamine. J Chromatogr 1991; 566: 187–94
  • Simpson J.J., Davies W.E. Recent advances in the pharmacological treatment of tinnitus. Trends Pharmacol Sci 1999; 20: 12–8
  • Sobkowicz H.M., August B.K., Slapnick S.M. Synaptic arrangements between inner hair cells and tunnel fibers in the mouse cochlea. Synapse 2004; 52: 299–315
  • Sobkowicz H.M., Slapnick S.M., August B.K. Reciprocal synapses between inner hair cell spines and afferent dendrites in the organ of corti of the mouse. Synapse 2003; 50: 53–66
  • Ueda S., Aso S., Watanabe Y., Mizukoshi K. Changes in auditory evoked responses during intravenous lidocaine. Acta Otolaryngol Suppl 1993; 504: 89–93

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.